A type 2 ryanodine receptor variant associated with reduced Ca2+ release and short-coupled torsades de pointes ventricular arrhythmia

Yusuke Fujii(Shiga University of Medical Science), Minoru Horie(Nagahama City Hospital), Takashi Murayama(Juntendo University), Hideki Itoh(Shiga University of Medical Science), Seiko Ohno(Shiga University of Medical Science), Malorie Blancard(Délégation Paris 5), Kimie Ohkubo(Nihon University), Tomoya Ozawa(Shiga University of Medical Science), Yoshihisa Nakagawa(Shiga University of Medical Science), Pascale Guicheney(Inserm), Hisaaki Aoki(Osaka International Cancer Institute), Satoshi Yamamoto(Tonan Hospital), Ichiro Watanabe(Nihon University), Mari Ichikawa(Shiga University of Medical Science), Keiko Sonoda(Shiga University of Medical Science), Yumie Matsui, Nagomi Kurebayashi(Juntendo University)
Heart Rhythm
October 18, 2016
10.1016/j.hrthm.2016.10.015
Cited by 88

Related Papers

Genotype-Phenotype Correlation in the Long-QT Syndrome
|Circulation|2001|1.8k
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death
|Nature Genetics|2013|550
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
|New England Journal of Medicine|1996|507